DU9-31955-86949
5 vaccinations
10 coded responses
58 check-ins
10 free-text entries
5 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 872 / NM
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-23
Registered in v-safe
- 2020-12-28
- 2020-12-29
-
2021-01-05
Survey response — day 14, dose 1MedDRA: Diarrhoea, Limb discomfort, Nausea, Pain in extremity, Sleep disorder, Vomiting — Feeling: Good · Be unable to do your normal daily activitiesFree text: Recurrence of arm pain and nausea, vomiting, and diarrhea, waking me from sleep and lasting about 3 hours. Could have been something I ate but thought I should mention it, especially with the arm discomfort which has continued intermittently.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities2 call case(s)
- 2021-01-12
-
2021-01-14
Dose 2 — Pfizer-BioNTech
- 2021-01-14
-
2021-01-15
Survey response — days 1–6 daily, dose 2MedDRA: Decreased appetite — Feeling: Fair · Site: Pain, Redness, Swelling · Joint pains, Fatigue or tirednessFree text: No appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-16
- 2021-01-17
- 2021-01-18
-
2021-01-19
Survey response — days 1–6 daily, dose 2MedDRA: Mood swings — Feeling: GoodFree text: Recent unusual mood swings. Uncharacteristic for me. Probably secondary to current events and the sad state of the human condition.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-20
Health check-in — days 1–6 daily, dose 2Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-15
- 2021-07-15
-
2021-09-24
Dose 3 — Pfizer-BioNTech
- 2021-09-24
-
2021-09-25
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-26
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessFree text: No appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-09-28
- 2021-09-29
- 2021-09-30
-
2021-10-03
Survey response — day 7, dose 3MedDRA: Vertigo — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Vertigo for 2 days. Im a physician and have never had vertigo in the past.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-08
- 2021-10-15
-
2021-10-22
Survey response — day 28, dose 3MedDRA: Headache, Vertigo — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Intermittent Headache and vertigo. Seems to bie improving.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-29
- 2021-11-05
-
2021-12-24
Survey response — 3 months, dose 3MedDRA: Abdominal pain upper, Decreased appetite, Weight decreased — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Gastric pain, anorexia, weight lossMedDRA releases: 2024-11 · check-in free text available
-
2021-12-24
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-27
-
2022-03-16
Dose 4 — Pfizer-BioNTech
-
2022-03-17
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Redness, Swelling · Chills, Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-03-18
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-03-19
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2022-03-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-03-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-03-22
- 2022-03-25
- 2022-03-30
-
2022-04-06
Survey response — day 21, dose 4MedDRA: Ear pain, Headache, Tinnitus — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Left ear tinnitus, pain, and headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-04-13
- 2022-04-20
- 2022-04-27
-
2022-06-15
Survey response — 3 months, dose 4MedDRA: Early satiety, Nausea, Unevaluable event, Weight decreased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Unexplained weight loss, nausea, early satiety · Healthcare visit (other): Also have referral to GIMedDRA releases: 2024-11 · check-in free text available
-
2022-06-15
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-16
- 2022-06-16
- 2022-06-16
-
2022-06-16
Call successfulParticipant prefers to complete VAERS report online
-
2022-09-14
Survey response — 6 months, dose 4MedDRA: Abdominal pain, Asthenia, COVID-19, Decreased appetite, Dehydration, Early satiety, Hospitalisation, Jejunostomy, Malnutrition, SARS-CoV-2 test negative, Weight decreased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Poor appetite, weight loss, early satiety and post prandial abdominal pain for 12 months. Got COVID on June 30, took Paxlovid and had a rebound at 4 days and two prior negative tests. I took a second pack and was better after 4-5 days. · Healthcare visit (other): After rebound I ended up in hospital for 10 days for dehydration, malnourishment, severe weakness and inability to consume adequate calories. I had a j tube placed on august 18MedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-09-15
- 2022-09-15
- 2022-09-15
- 2022-09-15
-
2022-10-11
Dose 5 — Moderna
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-17
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-08
- 2022-11-15
- 2022-11-22
- 2023-01-10
- 2023-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | No |
| 4 | 2022-03-16 | Pfizer-BioNTech | No |
| 5 | 2022-10-11 | Moderna | No |
Call center
5 call center cases
3 successful · 1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
1 wait over 3 months for a first call
Free text
Release 1 — day 14, dose 1
Symptoms: Recurrence of arm pain and nausea, vomiting, and diarrhea, waking me from sleep and lasting about 3 hours. Could have been something I ate but thought I should mention it, especially with the arm discomfort which has continued intermittently.
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): No appetite
Systemic reaction (other): Recent unusual mood swings. Uncharacteristic for me. Probably secondary to current events and the sad state of the human condition.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): No appetite
Release 9 — day 7, dose 3
Systemic reaction (other): Vertigo for 2 days. Im a physician and have never had vertigo in the past.
Release 10 — day 28, dose 3
Symptoms: Intermittent Headache and vertigo. Seems to bie improving.
Release 10 — 3 months, dose 3
Symptoms: Gastric pain, anorexia, weight loss
Release 11 — day 21, dose 4
Symptoms: Left ear tinnitus, pain, and headache
Release 12 — 3 months, dose 4
Symptoms: Unexplained weight loss, nausea, early satiety
Healthcare visit (other): Also have referral to GI
Release 12 — 6 months, dose 4
Symptoms: Poor appetite, weight loss, early satiety and post prandial abdominal pain for 12 months. Got COVID on June 30, took Paxlovid and had a rebound at 4 days and two prior negative tests. I took a second pack and was better after 4-5 days.
Healthcare visit (other): After rebound I ended up in hospital for 10 days for dehydration, malnourishment, severe weakness and inability to consume adequate calories. I had a j tube placed on august 18
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Asthenia | · | · | ✓ |
| HCVO | Dehydration | · | · | ✓ |
| HCVO | Hospitalisation | · | · | ✓ |
| HCVO | Jejunostomy | · | · | ✓ |
| HCVO | Malnutrition | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abdominal pain | · | · | ✓ |
| SD | Abdominal pain upper | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Early satiety | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Limb discomfort | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sleep disorder | ✓ | ✓ | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
| SD | Weight decreased | · | · | ✓ |
| SRO | Decreased appetite | ✓ | ✓ | ✓ |
| SRO | Mood swings | ✓ | ✓ | ✓ |
| SRO | Vertigo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release